USE OF NK-1 RECEPTOR ANTAGONISTS AGAINST BENIGN PROSTATIC HYPERPLASIA.

• 1. NK－1受体拮抗剂对抗良性前列腺增生的用途 [P] . 中国专利： CN100398106C . 2008.07.02
• 2. NK－1受体拮抗剂对抗良性前列腺增生的用途 [P] . 中国专利： CN1503684A . 2004-06-09
• 3. Use of NK-1 receptor antagonists against benign prostatic hyperplasia. [P] . ZA200308110B . 2005-01-17

  机译： NK-1受体拮抗剂对抗良性前列腺增生的用途。

• 4. Pharmaceutical composition containing an alpha - 1 receptor antagonist andrenergico a PDE5 inhibitor and / or an inhibitor of - 5 - reductase.Useful in the treatment of benign prostatic hyperplasia. [P] . CL2006000827A1 . 2006-10-06

  机译： 药物组合物，其包含α-1受体拮抗剂和能聚PDE5抑制剂和/或-5-还原酶抑制剂。用于治疗良性前列腺增生。

• 5. USE OF NK-1 RECEPTOR ANTAGONISTS AGAINST BENIGN PROSTATIC HYPERPLASIA [P] . CA2444395C . 2010-12-21

  机译： 使用NK-1受体拮抗剂对抗前列腺增生症

• 1. Growth Hormone Releasing Hormone Receptors Antagonists and Cancers: Do GHRH-R Antagonists Play a Role in the Management of Prostate Cancer? [J] . Joseph Bertin Alexis Zoa Bindzi, Yingjie Yang, Xiaoqi Yan, 泌尿学期刊（英文） . 2020,第006期
• 2. Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue [J] . Zong-Lin Wu, Ya Yuan, He Geng, 亚洲男性学杂志（英文版） . 2012,第002期
• 3. Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia [C] . Luciano Adorini, Giuseppe Penna, Benedetta Fibbi, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010
• 4. Sexually transmitted infections and prostatitis in the etiology of prostate cancer and benign prostatic hyperplasia. [D] . Sutcliffe, Siobhan. 2005
• 5. Impact of Intravesical Protrusion of the Prostate in the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia of Moderate Size by Alpha Receptor Antagonist [O] . Yu Mi Seo, Hyung Jee Kim 2012
• 6. The Changes of Prostate Specific Antigen (PSA) after Treatment with Alpha 1-Adorenergic Receptor Antagonists in Men with 4.0-9.9 ng/ml PSA Level: A Study for Comparison of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom (BPH/LUTS) and Prostate Cancer [O] . 花井 禎, 松本 成史, 小路 直, 2009
• 7. Bone Morphogenetic Proteins, Antagonists and Receptors in Prostate Cancer [R] . Reddi, A. H. 2005

• 1. Mechanisms of Prostate Atrophy after LHRH Antagonist Cetrorelix Injection： An Experimental Study in a Rat Model of Benign Prostatic Hyperplasia [J] . 杨栋 ,侯腾 ,杨雄 . 华中科技大学学报：医学英德文版 . 2012,第003期
• 2. Preclinical therapy of benign prostatic hyperplasia with neuropeptide hormone antagonists [J] . Petra Popovics123 ,Andrew V Schally3 ,Norman L Block34 . 世界临床泌尿杂志 . 2014,第003期
• 3. Androgen Receptor Roles in Benign and Malignant Prostate Disease [J] . Juan WANG ,Zhi-qun SHANG ,Yuan-jie NIU . 临床肿瘤和癌症研究 . 2011,第002期
• 4. 临床药师对抗菌药物使用强度及使用率的干预分析 [C] . 齐宏亮 ,周晖 ,张海林 . 2013年中国临床药学学术年会暨第九届中国临床药师论坛 . 2013
• 5. NK-1受体拮抗剂联合5-HT3受体拮抗剂+地塞米松预防乳腺癌化疗所致恶心呕吐的疗效及安全性的Meta分析 [A] . 侯佳林 . 2019